Efficacy and safety of intranasal insulin on postoperative cognitive dysfunction in elderly patients after laparoscopic radical resection of colorectal cancer: a double-blind pilot study
Hailong Zhang,Liqin Zhao,Min Li,Xu Li,Ruofan Li,Di Wu
DOI: https://doi.org/10.3389/fnagi.2024.1375841
IF: 4.8
2024-06-11
Frontiers in Aging Neuroscience
Abstract:Objective: To evaluate the efficacy and safety of intranasal insulin on postoperative cognitive dysfunction (POCD) in elderly patients after laparoscopic radical resection of colorectal cancer. Methods: Older patients scheduled for laparoscopic radical resection of colorectal cancer at Beijing Luhe Hospital, Capital Medical University, between August 2023 and November 2023, were enrolled in this double-blind pilot study. Patients were randomized to the control and insulin groups at a 1:1 ratio. The primary outcome was the rate of POCD at postoperative 7 days. Results: A total of 61 patients (30 in the insulin group) were analyzed. The insulin group had a significantly lower POCD rate compared with the control group at postoperative day 7 [4(13.3%) vs. 12 (38.7%), p = 0.024]. The serum levels of IL-6, TNF-α and S100β at T 2-5 in the insulin group were significantly lower than those of the control group (IL-6: mean difference at T 2 , −4.14, p = 0.036; T 3 , −3.84, p = 0.039; T 4 , −3.37, p = 0.013; T 5 , −2.57, p = 0.042; TNF-α: mean difference at T 2 , −3.19, p = 0.002; T 3 , −2.35, p = 0.028; T 4 , −2.30, p = 0.019; T 5 , −1.96, p = 0.0181; S100β: mean difference at T 2 , −8.30, p = 0.019; T 3 , −23.95, p = 0.020; T 4 , −20.01, p = 0.023; T 5 , −17.67, p = 0.010). No insulin allergic reactions, nasal irritation, or hypoglycemic reactions were observed in either of the groups. Conclusion: Intranasal insulin may decrease the risk of POCD and inhibit the elevated serum IL-6, TNF-α, and S100β levels in elderly patients after laparoscopic radical resection of colorectal cancer, which proves that intranasal insulin may be a promising therapeutic option for POCD. Clinical trial registration: Identifier, ChiCTR2300074423.
neurosciences,geriatrics & gerontology,gerontology